Friday September 16, 2011

08.30 – 09.00 Introduction,Philippe Métellus
                       Introduction, Anthony Gonçalves

12.15 – 12.35 A Rationale for on demand radiosurgery, Jean Régis

14.00 – 14.15 Symposium Brain Lab: Local control after SRT for brain metastases, Ruud Wiggenraad

15.15 – 15.45 Lesson from the EORTC Trial, Denys Fontaine

16.15 – 17.00 Lessons from primary tumors, Olivier Chinot

16.45 – 17.15 Is systemic anti-cancer therapy neurotoxic? Does "chemobrain" exist? And should we rename it? Sophie Taillibert

17.15 – 18.00 Neurocognitive decline WBRT vs. Intracranial progression, Hidefumi Aoyama

Saturday September 17, 2011

08.30 – 09.00 New pharmacological agents in brain metastases from breast . cancer: a comprehensive overview, Nancy U. Lin

09.15 – 09.35 Antiangiogenics in brain metastasis, Benjamin Besse

09.45 – 10.05 DNA Repair inhibition and tumor cell radiosensitization, David Azria

11.00 – 11.20 Leptomeningeal brain metastasis, Emilie Le Rhun

11.30 – 12.45 Clinical case studies: Interactive Session, CHAIRPERSON: Frédéric Dhermain

Top